Concepedia

Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial

H. C. Rümke, José-María Bayas, José-Ramón de Juanes, Covadonga Caso, Jan Hendrik Richardus, Magda Campins, Lars Rombo, Xavier Duval, Tino F. Schwarz, Francisco Abad‐Santos,

Vaccine · 2008 · 94 citations · 15 references

DOI

Concepts

References

15

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

John J. Treanor, James D. Campbell, Kenneth M. Zangwill et al. · New England Journal of Medicine · 2006 · 704 citations · Full text

, , +17

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 503 citations

, , +14

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

Karl G. Nicholson, Anthony Colegate, Audino Podda et al. · The Lancet · 2001 · 444 citations

, , +16

H5N1 Outbreaks and Enzootic Influenza

Robert G. Webster, Malik Peiris, Honglin Chen et al. · Emerging infectious diseases · 2006 · 416 citations · Full text

, , +17

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial

Jean-Louis Bresson, Christian Perronne, Odile Launay et al. · The Lancet · 2006 · 414 citations

, , +12